½ÃÀ庸°í¼­
»óǰÄÚµå
1279756

¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : ¼­ºñ½ºº°(¿î¼Û, â°í ¹× À¯Åë, ºÎ°¡°¡Ä¡ ¼­ºñ½º), ¿î¿µ À¯Çüº°(ÄݵåüÀÎ, ºñÄݵåüÀÎ) ¹× Áö¿ªº° ºÐ¼®(2022-2029³â)

Global Bio-Pharma Logistics Market Size study & Forecast, by Service (Transportation, Warehousing and Distribution, and Value-added Services), by Type of Operation (Cold Chain and Non-cold Chain), and Regional Analysis, 2022-2029

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹ÙÀÌ¿ÀÀǾàǰÀº Çö´ë °úÇÐÀÇ °¡Àå Áß¿äÇÑ ¼º°ú Áß ÇϳªÀÔ´Ï´Ù.

¹ÙÀÌ¿ÀÀǾàǰÀº Çö´ë °úÇÐÀÇ °¡Àå Áß¿äÇÑ ¼º°ú Áß ÇϳªÀ̸ç, °ÅÀÇ ¸ðµç ÀÇ·á ºÐ¾ß¿¡¼­ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¾Ï, ´ë»ç¼º Áúȯ µî ´Ù¾çÇÑ Áúº´¿¡ ´ëÇÑ °¡Àå È¿°úÀûÀÎ ÀÓ»ó Ä¡·á¹ý Áß Çϳª·Î ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È­¹°ÀÇ ¿î¼Û ¹× º¸°üÀ» ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù¶ó°í ÇÕ´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀåÀº ¹ÙÀÌ¿ÀÀǾàǰ »ê¾÷ÀÇ ºÎ»ó°ú ¹°·ù¿¡ ´ëÇÑ ÅõÀÚ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ¹ÙÀÌ¿ÀÀǾàǰ »ê¾÷ÀÇ ºÎ»óÀº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå¿¡ À¯¸®ÇÑ ¼ö¿ä¸¦ âÃâÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, Statista¿¡ µû¸£¸é 2021³â ¼¼°è ¹ÙÀÌ¿ÀÀǾàǰ »ê¾÷Àº ¾à 7Á¶ 1,500¾ï ´Þ·¯ÀÇ °¡Ä¡¸¦ ´Þ¼ºÇßÀ¸¸ç, 2020³â¿¡´Â ¾à 6Á¶ 6,500¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, Àç»ýÀÇ·áÀÇ ºÎ»ó°ú ½ÃÀå °ü°èÀÚµéÀÇ ¿¬±¸°³¹ß Ȱµ¿ÀÌ È°¹ßÇØÁö¸é¼­ ½ÃÀåÀÇ À¯¸®ÇÑ ±âȸ¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª 2022-2029³â ¿¹Ãø ±â°£ µ¿¾È ³ôÀº ¿î¿µ ºñ¿ëÀº ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, Áß³²¹Ì, ±âŸ Áö¿ªÀÔ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¹ÙÀÌ¿ÀÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ±âħ¾à, °¨±â¾à, À§Àå¾à ¹× ÇǺΰú Á¦Ç°ÀÇ Áõ°¡·Î ÀÎÇØ ¼öÀÍ Ãø¸é¿¡¼­ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àüü Á¦¾à »ê¾÷ÀÇ ¼ºÀå Áõ°¡¿Í ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå Âü¿©ÀÚµéÀÇ ¼ºÀå Ȱµ¿ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â µ¿¾È ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇöȲ
  • ¼¼°è ½ÃÀ塤ºÎ¹®º° ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2019-2029³â
    • ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀå, Áö¿ªº°, 2019-2029³â
    • ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀå : ¼­ºñ½ºº°, 2019-2029³â
    • ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀå, ¿î¿µ À¯Çüº°, 2019-2029³â
  • ÁÖ¿ä µ¿Çâ
  • ¿¹Ãø ¹æ¹ý
  • Á¶»ç °¡Á¤

Á¦2Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • Á¶»ç ´ë»ó ¹üÀ§
    • »ê¾÷ ÁøÈ­
  • Á¶»ç ´ë»ó ¿¬µµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀå ¿ªÇÐ

  • ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀåÀÇ ¿µÇ⠺м®(2019-2029³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
      • ¹ÙÀÌ¿À Á¦¾à »ê¾÷ ´ëµÎ
      • ¹°·ù¿¡ ´ëÇÑ ÅõÀÚ
    • ½ÃÀå °úÁ¦
      • ¿î¿µ ºñ¿ë »ó½Â
    • ½ÃÀå ±âȸ
      • Àç»ýÀÇ·á ´ëµÎ
      • ½ÃÀå °ü°èÀÚÀÇ ¿¬±¸°³¹ß Ȱµ¿ Ȱ¹ßÈ­

Á¦4Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's 5 Force ¸ðµ¨ÀÇ ¹Ì·¡ÁöÇâÀû Á¢±Ù¹ý(2019-2029³â)
  • PEST ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • ¾÷°è Àü¹®°¡ÀÇ Àü¸Á
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦5Àå À§Çè Æò°¡ : COVID-19ÀÇ ¿µÇâ

  • COVID-19°¡ ¾÷°è¿¡ ¹ÌÄ¡´Â ÀüüÀûÀÎ ¿µÇâ¿¡ ´ëÇÑ Æò°¡
  • COVID-19 ÀÌÀü°ú COVID-19 ÀÌÈÄ ½ÃÀå ½Ã³ª¸®¿À

Á¦6Àå ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ¼¼°è ½ÃÀå, ¼­ºñ½ºº°

  • ½ÃÀå ÇöȲ
  • ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ¼¼°è ½ÃÀå : ¼­ºñ½ºº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ¼¼°è ½ÃÀå, ¼­ºñ½ºº° ÃßÁ¤¡¤¿¹Ãø, 2019-2029
  • ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • ¿î¼Û
    • â°í¡¤À¯Åë
    • ºÎ°¡°¡Ä¡ ¼­ºñ½º

Á¦7Àå ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ¼¼°è ½ÃÀå : ¿î¿µ À¯Çüº°

  • ½ÃÀå ÇöȲ
  • ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ¼¼°è ½ÃÀå : ¿î¿µ À¯Çüº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ¼¼°è ½ÃÀå, ¿î¿µ À¯Çüº° ÃßÁ¤¡¤¿¹Ãø, 2019-2029
  • ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • ÄݵåüÀÎ
    • ºñÄݵåüÀÎ

Á¦8Àå ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ¼¼°è ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • ¼­ºñ½ºº° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
      • ¿î¿µ À¯Çüº° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
    • ij³ª´Ù
  • À¯·´ ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ¹ÙÀÌ¿ÀÀǾàǰ ¹°·ù ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • ¼¼°è ±âŸ Áö¿ª

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Deutsche Post DHL Group
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì¿¡ ÇÑÇÔ)
      • Á¦Ç° °³¿ä
      • ÃÖ±ÙÀÇ µ¿Çâ
    • Kuehne+Nagel
    • UPS(Marken)
    • DB Schenker
    • FedEx
    • Nippon Express
    • World Courier
    • SF Express
    • DSV
    • CEVA

Á¦10Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • ½ÂÀÎ
    • ÃâÆÇ
  • Á¶»ç Ư¡
  • Á¶»ç °¡Á¤
ksm 23.06.13

The Global Bio-Pharma Logistics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Biopharmaceuticals are among the most significant achievements of modern science. These drugs are increasingly being used in almost all fields of medicine. They have evolved into one of the most effective clinical treatment modalities for a wide range of diseases, including cancer and metabolic disorders. The transportation and storage of these consignments are referred to as bio-pharma logistics. The Bio-Pharma Logistics market is expanding because of factors such as the rising bio-pharmaceutical industry and investment in logistics.

Moreover, the rising Bio-pharma industry is anticipated to create the lucrative demand for the market during forecast period. According to Statista, in 2021, the global biopharmaceutical industry attained a value of worth around USD 7.15 trillion dollars. In 2020, it was around USD 6.65 trillion. Additionally, the rising emergence of regenerative medicines and growing R&D activities by market players is anticipated to propel the lucrative opportunities for the market. However, higher operational costs hamper market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Bio-Pharma Logistics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia Pacific dominated the market in terms of revenue, owing to the increasing demand for biopharmaceutical medicines, growing incidences of cough, cold drugs, and gastrointestinal and dermatology products.

Whereas the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing growth across the pharmaceutical industry, and rising growth activities by market players in the forecast period.

Major market players included in this report are:

  • Deutsche Post DHL Group
  • Kuehne + Nagel
  • UPS (Marken)
  • DB Schenker
  • FedEx
  • Nippon Express
  • World Courier
  • SF Express
  • DSV
  • CEVA

Recent Developments in the Market:

  • In September 2021, Nippon Express Co. Ltd announced that it is developing pharmaceutical supply chain networks that meet both hardware and software requirements for good distribution practices, allowing for a safer and more secure pharmaceutical supply.
  • In August 2020, UPS constructed two massive freezer farms capable of super-cooling millions of vials of a COVID-19 vaccine in preparation for the day when the medicine might need to be delivered at high speed around the world.

Global Bio-Pharma Logistics Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Services, Type of Operation, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Service:

  • Transportation
  • Warehousing and Distribution
  • Value Added Services

By Type Of Operation:

  • Cold Chain
  • Non-cold Chain

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Bio-Pharma Logistics Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Bio-Pharma Logistics Market, by Service, 2019-2029 (USD Billion)
    • 1.2.3. Bio-Pharma Logistics Market, by Type of Operation, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Bio-Pharma Logistics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Bio-Pharma Logistics Market Dynamics

  • 3.1. Bio-Pharma Logistics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising bio-pharmaceutical industry
      • 3.1.1.2. Investment in logistics
    • 3.1.2. Market Challenges
      • 3.1.2.1. Higher operational costs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising emergence of regenerative medicines
      • 3.1.3.2. Growing R&D activities by market players

Chapter 4. Global Bio-Pharma Logistics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Bio-Pharma Logistics Market, by Service

  • 6.1. Market Snapshot
  • 6.2. Global Bio-Pharma Logistics Market by Service, Performance - Potential Analysis
  • 6.3. Global Bio-Pharma Logistics Market Estimates & Forecasts by Service 2019-2029 (USD Billion)
  • 6.4. Bio-Pharma Logistics Market, Sub-Segment Analysis
    • 6.4.1. Transportation
    • 6.4.2. Warehousing and Distribution
    • 6.4.3. Value Added Services

Chapter 7. Global Bio-Pharma Logistics Market, by Type of Operation

  • 7.1. Market Snapshot
  • 7.2. Global Bio-Pharma Logistics Market by Type of Operation, Performance - Potential Analysis
  • 7.3. Global Bio-Pharma Logistics Market Estimates & Forecasts by Type of Operation 2019-2029 (USD Billion)
  • 7.4. Bio-Pharma Logistics Market, Sub Segment Analysis
    • 7.4.1. Cold Chain
    • 7.4.2. Non-cold Chain

Chapter 8. Global Bio-Pharma Logistics Market, Regional Analysis

  • 8.1. Bio-Pharma Logistics Market, Regional Market Snapshot
  • 8.2. North America Bio-Pharma Logistics Market
    • 8.2.1. U.S. Bio-Pharma Logistics Market
      • 8.2.1.1. Service breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Type of Operation breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Bio-Pharma Logistics Market
  • 8.3. Europe Bio-Pharma Logistics Market Snapshot
    • 8.3.1. U.K. Bio-Pharma Logistics Market
    • 8.3.2. Germany Bio-Pharma Logistics Market
    • 8.3.3. France Bio-Pharma Logistics Market
    • 8.3.4. Spain Bio-Pharma Logistics Market
    • 8.3.5. Italy Bio-Pharma Logistics Market
    • 8.3.6. Rest of Europe Bio-Pharma Logistics Market
  • 8.4. Asia-Pacific Bio-Pharma Logistics Market Snapshot
    • 8.4.1. China Bio-Pharma Logistics Market
    • 8.4.2. India Bio-Pharma Logistics Market
    • 8.4.3. Japan Bio-Pharma Logistics Market
    • 8.4.4. Australia Bio-Pharma Logistics Market
    • 8.4.5. South Korea Bio-Pharma Logistics Market
    • 8.4.6. Rest of Asia Pacific Bio-Pharma Logistics Market
  • 8.5. Latin America Bio-Pharma Logistics Market Snapshot
    • 8.5.1. Brazil Bio-Pharma Logistics Market
    • 8.5.2. Mexico Bio-Pharma Logistics Market
    • 8.5.3. Rest of Latin America Bio-Pharma Logistics Market
  • 8.6. Rest of The World Bio-Pharma Logistics Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Deutsche Post DHL Group
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Kuehne + Nagel
    • 9.2.3. UPS (Marken)
    • 9.2.4. DB Schenker
    • 9.2.5. FedEx
    • 9.2.6. Nippon Express
    • 9.2.7. World Courier
    • 9.2.8. SF Express
    • 9.2.9. DSV
    • 9.2.10. CEVA

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦